Amimachi, Japan

Motokuni Mori

This inventor holds 5 USPTO granted patents. Top assignees: Mitsubishi Yuka Pharmaceutical Co., Ltd., Mitsubishi Petrochemical Company Limited. Active years: 1980-1985.


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 4

Forward Citations = 65(Granted Patents)


Location History:

  • Ami, JP (1980 - 1982)
  • Amimachi, JP (1982 - 1985)

Company Filing History:


Years Active: 1980-1985

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Motokuni Mori: Innovator in Cholesterol Reduction

Introduction

Motokuni Mori is a notable inventor based in Amimachi, Japan. He has made significant contributions to the field of cholesterol reduction through his innovative patents. With a total of five patents to his name, Mori has focused on developing effective solutions for managing cholesterol levels.

Latest Patents

Among his latest patents is the development of anticholesteremic anion exchange resins. This polymeric cholesterol-reducing agent features vinylimidazole pendant groups. The invention provides a cholesterol-reducing agent that contains an anion exchange resin with a functional group of an imidazolium salt. This agent demonstrates high selectivity for the adsorption of bile acids and is noted for having no unpleasant odor.

Career Highlights

Mori has worked with prominent companies in the pharmaceutical and petrochemical industries. He has been associated with Mitsubishi Yuka Pharmaceutical Co., Ltd. and Mitsubishi Petrochemical Company Limited. His work in these organizations has contributed to advancements in health-related innovations.

Collaborations

Mori has collaborated with notable colleagues, including Toshiji Kanayama and Kunio Kihara. Their combined expertise has likely enhanced the development of his innovative solutions.

Conclusion

Motokuni Mori's contributions to cholesterol reduction through his patents highlight his role as a significant inventor in the field. His work continues to impact health and wellness positively.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…